{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:32:50Z","timestamp":1790249570469,"version":"4.1.0"},"reference-count":165,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.phrs.2011.05.005","type":"journal-article","created":{"date-parts":[[2011,6,5]],"date-time":"2011-06-05T19:31:29Z","timestamp":1307302289000},"page":"551-560","source":"Crossref","is-referenced-by-count":88,"title":["Matrix metalloproteinase inhibitor properties of tetracyclines: Therapeutic potential in cardiovascular diseases"],"prefix":"10.1016","volume":"64","author":[{"given":"Michele M.","family":"Castro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arulmozhi D.","family":"Kandasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nermeen","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2011.05.005_bib0495","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1073\/pnas.48.6.1014","article-title":"Collagenolytic activity in amphibian tissues: a tissue culture assay","volume":"48","author":"Gross","year":"1962","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.phrs.2011.05.005_bib0500","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.yexcr.2005.11.022","article-title":"Making the cut: Protease-mediated regulation of angiogenesis","volume":"312","author":"Roy","year":"2006","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.phrs.2011.05.005_bib0505","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1101\/gad.815400","article-title":"Matrix metalloproteinases: effectors of development and normal physiology","volume":"14","author":"Vu","year":"2000","journal-title":"Genes Dev"},{"key":"10.1016\/j.phrs.2011.05.005_bib0510","doi-asserted-by":"crossref","first-page":"II43","DOI":"10.1136\/ard.62.suppl_2.ii43","article-title":"Metalloproteinases, inflammation, and rheumatoid arthritis","volume":"62","author":"Mohammed","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.phrs.2011.05.005_bib0515","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10555-006-7886-9","article-title":"Matrix metalloproteinases and tumor metastasis","volume":"25","author":"Deryugina","year":"2006","journal-title":"Cancer Metast Rev"},{"key":"10.1016\/j.phrs.2011.05.005_bib0030","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1196\/annals.1383.034","article-title":"Matrix metalloproteinase-2: the forgotten enzyme in aneurysm pathogenesis","author":"Thompson","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.phrs.2011.05.005_bib0035","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/01.RES.0000070112.80711.3D","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry","volume":"92","author":"Visse","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.phrs.2011.05.005_bib0520","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/res.90.3.251","article-title":"Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly","volume":"90","author":"Galis","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.phrs.2011.05.005_bib0525","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.atherosclerosis.2007.10.011","article-title":"Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats","volume":"198","author":"Castro","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phrs.2011.05.005_bib0530","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/hh1501.094396","article-title":"Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?","volume":"89","author":"Creemers","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.phrs.2011.05.005_bib0535","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1161\/01.RES.77.5.863","article-title":"Matrix metalloproteinases and cardiovascular disease","volume":"77","author":"Dollery","year":"1995","journal-title":"Circ Res"},{"key":"10.1016\/j.phrs.2011.05.005_bib0540","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0008-6363(99)00431-9","article-title":"Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target","volume":"46","author":"Spinale","year":"2000","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.phrs.2011.05.005_bib0545","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1161\/01.CIR.101.15.1833","article-title":"Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart","volume":"101","author":"Cheung","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2011.05.005_bib0550","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1146\/annurev.pharmtox.47.120505.105230","article-title":"Intracellular targets of matrix metalloproteinase-2 in cardiac disease: rationale and therapeutic approaches","volume":"47","author":"Schulz","year":"2007","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.phrs.2011.05.005_bib0555","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/01.CIR.0000028818.33488.7B","article-title":"Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury","volume":"106","author":"Wang","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2011.05.005_bib0560","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0008-6363(02)00719-8","article-title":"Matrix metalloproteinase-2 mediates cytokine-induced myocardial contractile dysfunction","volume":"57","author":"Gao","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.phrs.2011.05.005_bib0565","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1161\/CIRCULATIONAHA.104.531616","article-title":"Degradation of myosin light chain in isolated rat hearts subjected to ischemia-reperfusion injury: a new intracellular target for matrix metalloproteinase-2","volume":"112","author":"Sawicki","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2011.05.005_bib0570","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.yjmcc.2007.07.055","article-title":"Matrix metalloproteinase-2 degrades the cytoskeletal protein alpha-actinin in peroxynitrite mediated myocardial injury","volume":"43","author":"Sung","year":"2007","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.phrs.2011.05.005_bib0575","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1161\/CIRCULATIONAHA.109.930222","article-title":"Titin is a target of MMP-2: implications in myocardial ischemia\/reperfusion injury","volume":"122","author":"Ali","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2011.05.005_bib0580","first-page":"H777","article-title":"Matrix metalloproteinase synthesis and expression in isolated LV myocyte preparations","volume":"277","author":"Coker","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.phrs.2011.05.005_bib0585","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1172\/JCI117619","article-title":"Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques","volume":"94","author":"Galis","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.phrs.2011.05.005_bib0590","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1042\/bj2960803","article-title":"Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells, Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester","volume":"296","author":"Hanemaaijer","year":"1993","journal-title":"Biochem J"},{"key":"10.1016\/j.phrs.2011.05.005_bib0595","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/13459","article-title":"Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure","volume":"5","author":"Heymans","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.phrs.2011.05.005_bib0600","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.matbio.2009.11.005","article-title":"Imbalance between matrix metalloproteinases and tissue inhibitor of metalloproteinases in hypertensive vascular remodeling","volume":"29","author":"Castro","year":"2010","journal-title":"Matrix Biol"},{"key":"10.1016\/j.phrs.2011.05.005_bib0605","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/03008209809023913","article-title":"Role of matrix proteases in processing enamel proteins","volume":"39","author":"Woessner","year":"1998","journal-title":"Connect Tissue Res"},{"key":"10.1016\/j.phrs.2011.05.005_bib0610","doi-asserted-by":"crossref","first-page":"21491","DOI":"10.1074\/jbc.274.31.21491","article-title":"Matrix metalloproteinases","volume":"274","author":"Nagase","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.phrs.2011.05.005_bib0615","doi-asserted-by":"crossref","first-page":"29596","DOI":"10.1074\/jbc.M102417200","article-title":"Activation of matrix metalloproteinases by peroxynitrite-induced protein S-glutathiolation via disulfide S-oxide formation","volume":"276","author":"Okamoto","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.phrs.2011.05.005_bib0620","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.1073\/pnas.87.14.5578","article-title":"The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family","volume":"87","author":"Van Wart","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.phrs.2011.05.005_bib0625","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1006\/abbi.1997.0127","article-title":"Activation of human neutrophil procollagenase by nitrogen dioxide and peroxynitrite: a novel mechanism for procollagenase activation involving nitric oxide","volume":"342","author":"Okamoto","year":"1997","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.phrs.2011.05.005_bib0630","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.bcp.2008.11.004","article-title":"Activation and modulation of 72 kDa matrix metalloproteinase-2 by peroxynitrite and glutathione","volume":"77","author":"Viappiani","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.phrs.2011.05.005_bib0635","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1095\/biolreprod43.6.956","article-title":"Identification of type IV collagenase in rat testicular cell culture: influence of peritubular-Sertoli cell interactions","volume":"43","author":"Sang","year":"1990","journal-title":"Biol Reprod"},{"key":"10.1016\/j.phrs.2011.05.005_bib0640","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1042\/bj20020707","article-title":"A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimers","volume":"369","author":"Bergman","year":"2003","journal-title":"Biochem J"},{"key":"10.1016\/j.phrs.2011.05.005_bib0645","doi-asserted-by":"crossref","first-page":"H1838","DOI":"10.1152\/ajpheart.00026.2006","article-title":"Cardiac ischemia-reperfusion injury induces matrix metalloproteinase-2 expression through the AP-1 components FosB and JunB","volume":"291","author":"Alfonso-Jaume","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.phrs.2011.05.005_bib0650","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1016\/j.febslet.2007.07.058","article-title":"High glucose enhances MMP-2 production in adventitial fibroblasts via Akt1-dependent NF-kappaB pathway","volume":"581","author":"Lee","year":"2007","journal-title":"FEBS Letters"},{"key":"10.1016\/j.phrs.2011.05.005_bib0655","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1161\/01.CIR.0000115521.95662.7A","article-title":"Pressure-induced matrix metalloproteinase-9 contributes to early hypertensive remodeling","volume":"109","author":"Lehoux","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2011.05.005_bib0660","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1161\/01.RES.0000015588.70132.DC","article-title":"Regulation of endothelial matrix metalloproteinase-2 by hypoxia\/reoxygenation","volume":"90","author":"Ben-Yosef","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.phrs.2011.05.005_bib0665","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.cardiores.2005.10.004","article-title":"Pathways of matrix metalloproteinase induction in heart failure: bioactive molecules and transcriptional regulation","volume":"69","author":"Deschamps","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.phrs.2011.05.005_bib0670","doi-asserted-by":"crossref","first-page":"14487","DOI":"10.1074\/jbc.M207309200","article-title":"Osteopontin induces nuclear factor kappa B-mediated promatrix metalloproteinase-2 activation through I kappa B alpha \/IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways","volume":"278","author":"Philip","year":"2003","journal-title":"J Biol Chem."},{"key":"10.1016\/j.phrs.2011.05.005_bib0675","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1161\/01.CIR.102.16.1944","article-title":"A matrix metalloproteinase induction\/activation system exists in the human left ventricular myocardium and is upregulated in heart failure","volume":"102","author":"Spinale","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2011.05.005_bib0680","doi-asserted-by":"crossref","first-page":"C867","DOI":"10.1152\/ajpcell.00161.2006","article-title":"Interleukin-1beta increases expression and activity of matrix metalloproteinase-2 in cardiac microvascular endothelial cells: role of PKC alpha\/beta1 and MAPKs","volume":"292","author":"Mountain","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.phrs.2011.05.005_bib0685","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bbrc.2010.04.067","article-title":"Role of AP-1 and RE-1 binding sites in matrix metalloproteinase-2 transcriptional regulation in skeletal muscle atrophy","volume":"396","author":"Liu","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.phrs.2011.05.005_bib0690","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1096\/fj.06-7938com","article-title":"Regulation of matrix metalloproteinase-2 (MMP-2) activity by phosphorylation","volume":"21","author":"Sariahmetoglu","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.phrs.2011.05.005_bib0215","unstructured":"Sariahmetoglu M, Skrzypiec M, Youssef N, Sawicka J, Holmes C, Sawicki G, Schulz R. Maintaining matrix metalloproteinase- 2 in its phosphorylated form protects the heart from ischemia\/reperfusion injury. J Mol Cell Cardiol (submitted for publication)."},{"key":"10.1016\/j.phrs.2011.05.005_bib0220","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1242\/jcs.00063","article-title":"Metalloproteinase inhibitors: biological actions and therapeutic opportunities","volume":"115","author":"Baker","year":"2002","journal-title":"J Cell Sci"},{"key":"10.1016\/j.phrs.2011.05.005_bib0695","first-page":"1","article-title":"Tissue inhibitors of metalloproteinases: evolution, structure and function","volume":"7","author":"Brew","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.phrs.2011.05.005_bib0700","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1016\/S0021-9258(18)42873-6","article-title":"Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin","volume":"267","author":"Goldberg","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.phrs.2011.05.005_bib0705","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1440-1681.2007.04573.x","article-title":"Angiotensin II increases tissue-specific inhibitor of metalloproteinase-2 expression in rat aortic smooth muscle cells in vivo: evidence of a pressure-independent effect","volume":"34","author":"Castoldi","year":"2007","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.phrs.2011.05.005_bib0710","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0008-6363(02)00546-1","article-title":"Collagen degradation in a murine myocarditis model: relevance of matrix metalloproteinase in association with inflammatory induction","volume":"56","author":"Li","year":"2002","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.phrs.2011.05.005_bib0715","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0167-4889(95)00205-7","article-title":"Angiotensin II induces TIMP-1 production in rat heart endothelial cells","volume":"28","author":"Chua","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.phrs.2011.05.005_bib0720","doi-asserted-by":"crossref","first-page":"H635","DOI":"10.1152\/ajpheart.00986.2001","article-title":"Ang II increases TIMP-1 expression in rat aortic smooth muscle cells in vivo","volume":"284","author":"Castoldi","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.phrs.2011.05.005_bib0725","doi-asserted-by":"crossref","first-page":"17321","DOI":"10.1016\/S0021-9258(18)41928-X","article-title":"A new inhibitor of metalloproteinases from chicken: ChIMP-3. A third member of the timp family","volume":"267","author":"Pavloff","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.phrs.2011.05.005_bib0730","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1161\/01.CIR.0000134959.83967.2D","article-title":"TIMP-3 deficiency leads to dilated cardiomyopathy","volume":"110","author":"Fedak","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2011.05.005_bib0735","doi-asserted-by":"crossref","first-page":"I365","DOI":"10.1161\/CIRCULATIONAHA.105.000810","article-title":"Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with Marfan syndrome","volume":"114","author":"Ikonomidis","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2011.05.005_bib0740","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0014-5793(96)01474-3","article-title":"Murine tissue inhibitor of metalloproteinases-4 (TIMP-4): cDNA isolation and expression in adult mouse tissues","volume":"401","author":"Leco","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1016\/j.phrs.2011.05.005_bib0745","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1161\/01.CIR.0000065603.09430.58","article-title":"Imbalance between tissue inhibitor of metalloproteinase-4 and matrix metalloproteinases during acute myocardial ischemia-reperfusion injury","volume":"107","author":"Schulze","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2011.05.005_bib0750","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1161\/01.CIR.0000127429.53391.78","article-title":"Attenuation of oxidative stress and remodeling by cardiac inhibitor of metalloproteinase protein transfer","volume":"109","author":"Cox","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2011.05.005_bib0755","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1023\/B:HREV.0000011395.11179.af","article-title":"Matrix metalloproteinase inhibitor development and the remodeling of drug discovery","volume":"9","author":"Peterson","year":"2004","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.phrs.2011.05.005_bib0760","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s000110050573","article-title":"ONO-4817, an orally active matrix metalloproteinase inhibitor, prevents lipopolysaccharide-induced proteoglycan release from the joint cartilage in guinea pigs","volume":"49","author":"Yamada","year":"2000","journal-title":"Inflamm Res"},{"key":"10.1016\/j.phrs.2011.05.005_bib0765","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/11703","article-title":"Tumor targeting with a selective gelatinase inhibitor","volume":"17","author":"Koivunen","year":"1999","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.phrs.2011.05.005_bib0770","doi-asserted-by":"crossref","first-page":"14020","DOI":"10.1074\/jbc.M212264200","article-title":"Identification of a region of beta-amyloid precursor protein essential for its gelatinase A inhibitory activity","volume":"278","author":"Higashi","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.phrs.2011.05.005_bib0775","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1600-0765.1983.tb00388.x","article-title":"Minocycline reduces gingival collagenolytic activity during diabetes. Preliminary observations and a proposed new mechanism of action","volume":"18","author":"Golub","year":"1983","journal-title":"J Periodontal Res"},{"key":"10.1016\/j.phrs.2011.05.005_bib0780","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1600-0765.1984.tb01334.x","article-title":"Tetracyclines inhibit tissue collagenase activity. A new mechanism in the treatment of periodontal disease","volume":"19","author":"Golub","year":"1984","journal-title":"J Periodontal Res"},{"key":"10.1016\/j.phrs.2011.05.005_bib0785","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/08959374980120010501","article-title":"Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms","volume":"12","author":"Golub","year":"1998","journal-title":"Adv Dent Res"},{"key":"10.1016\/j.phrs.2011.05.005_bib0790","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1902\/jop.2004.75.3.453","article-title":"Subantimicrobial dose doxycycline efficacy as a matrix metalloproteinase inhibitor in chronic periodontitis patients is enhanced when combined with a non-steroidal anti-inflammatory drug","volume":"75","author":"Lee","year":"2004","journal-title":"J Periodontol"},{"key":"10.1016\/j.phrs.2011.05.005_bib0795","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/sj.bjp.0707344","article-title":"Acute actions and novel targets of matrix metalloproteinases in the heart and vasculature","volume":"152","author":"Chow","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.phrs.2011.05.005_bib0800","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/01.CIR.0000089090.05757.34","article-title":"Early short-term treatment with doxycycline modulates postinfarction left ventricular remodeling","volume":"108","author":"Villarreal","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2011.05.005_bib0805","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/bjp.2008.373","article-title":"Protective action of doxycycline against diabetic cardiomyopathy in rats","volume":"155","author":"Yaras","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.phrs.2011.05.005_bib0810","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S1474-4422(04)00937-8","article-title":"The promise of minocycline in neurology","volume":"3","author":"Yong","year":"2004","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.phrs.2011.05.005_bib0815","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1177\/00220345870660080401","article-title":"A non-antibacterial chemically-modified tetracycline inhibits mammalian collagenase activity","volume":"66","author":"Golub","year":"1987","journal-title":"J Dent Res"},{"key":"10.1016\/j.phrs.2011.05.005_bib0820","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1006\/jsre.2001.6180","article-title":"Metalloproteinase inhibition prevents acute respiratory distress syndrome","volume":"99","author":"Carney","year":"2001","journal-title":"J Surg Res"},{"key":"10.1016\/j.phrs.2011.05.005_bib0825","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/00024382-200309000-00014","article-title":"Inhibition of matrix metalloproteinases by chemically modified tetracyclines in sepsis","volume":"20","author":"Maitra","year":"2003","journal-title":"Shock"},{"key":"10.1016\/j.phrs.2011.05.005_bib0830","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/01.shk.0000180619.06317.2c","article-title":"Chemically modified tetracycline prevents the development of septic shock and acute respiratory distress syndrome in a clinically applicable porcine model","volume":"24","author":"Steinberg","year":"2005","journal-title":"Shock"},{"key":"10.1016\/j.phrs.2011.05.005_bib0835","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0022-4804(03)00089-1","article-title":"Metalloproteinase inhibition reduces lung injury and improves survival after cecal ligation and puncture in rats","volume":"111","author":"Steinberg","year":"2003","journal-title":"J Surg Res"},{"key":"10.1016\/j.phrs.2011.05.005_bib0365","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ijcard.2005.07.042","article-title":"Chemically modified tetracyclines (CMT-3 and CMT-8) enable control of the pathologic remodellation of human aortic valve stenosis via MMP-9 and VEGF inhibition","volume":"111","author":"Salo","year":"2006","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.phrs.2011.05.005_bib0370","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/10454411910020030201","article-title":"Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs","volume":"2","author":"Golub","year":"1991","journal-title":"Crit Rev Oral Biol Med"},{"key":"10.1016\/j.phrs.2011.05.005_bib0840","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1600-0765.1993.tb01082.x","article-title":"Inhibition of epithelial cell matrix metalloproteinases by tetracyclines","volume":"28","author":"Nip","year":"1993","journal-title":"J Periodontal Res"},{"key":"10.1016\/j.phrs.2011.05.005_bib1285","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.phrs.2010.10.008","article-title":"Antimicrobial and non-antimicrobial tetracyclines in human cancer trials","volume":"63","author":"Richards","year":"2011","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.phrs.2011.05.005_bib0850","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nrm2125","article-title":"Matrix metalloproteinases and the regulation of tissue remodelling","volume":"8","author":"Page-McCaw","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.phrs.2011.05.005_bib0855","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1006\/jmcc.2000.1137","article-title":"Altered balance between extracellular proteolysis and antiproteolysis is associated with adaptive coronary arteriogenesis","volume":"32","author":"Cai","year":"2000","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.phrs.2011.05.005_bib0860","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1017\/S1431927605050440","article-title":"Cross talk between cell-cell and cell-matrix adhesion signaling pathways during heart organogenesis: implications for cardiac birth defects","volume":"11","author":"Linask","year":"2005","journal-title":"Microsc Microanal"},{"key":"10.1016\/j.phrs.2011.05.005_bib0865","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/dvdy.20377","article-title":"Cardiac morphogenesis: matrix metalloproteinase coordination of cellular mechanisms underlying heart tube formation and directionality of looping","volume":"233","author":"Linask","year":"2005","journal-title":"Dev Dyn"},{"key":"10.1016\/j.phrs.2011.05.005_bib0870","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s003950200011","article-title":"Embryogenesis of the rat heart: the expression of collagenases","volume":"97","author":"Ratajska","year":"2002","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.phrs.2011.05.005_bib0875","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0014-5793(01)02897-6","article-title":"Diminished corneal angiogenesis in gelatinase A-deficient mice","volume":"508","author":"Kato","year":"2001","journal-title":"FEBS Lett"},{"key":"10.1016\/j.phrs.2011.05.005_bib0880","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.1038\/sj.onc.1207688","article-title":"Mutations in two matrix metalloproteinase genes, MMP-2 and MT1-MMP, are synthetic lethal in mice","volume":"23","author":"Oh","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2011.05.005_bib0885","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.coph.2007.12.007","article-title":"Targeting Na+\/H+ exchanger regulation for cardiac protection: a RSKy approach?","volume":"8","author":"Avkiran","year":"2008","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.phrs.2011.05.005_bib0890","doi-asserted-by":"crossref","first-page":"952","DOI":"10.2174\/138955708785132819","article-title":"Pharmacological pre- and post- conditioning agents: reperfusion-injury of the heart revisited","volume":"8","author":"Andreadou","year":"2008","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.phrs.2011.05.005_bib0895","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1734-1140(09)70002-7","article-title":"The past, the present and the future of experimental research on myocardial ischemia and protection","volume":"61","author":"Ostadal","year":"2009","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.phrs.2011.05.005_bib0900","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0008-6363(96)00254-4","article-title":"Generation of peroxynitrite contributes to ischemia-reperfusion injury in isolated rat hearts","volume":"33","author":"Yasmin","year":"1997","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.phrs.2011.05.005_bib0905","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0014-5793(96)00065-8","article-title":"Inactivation of tissue inhibitor of metalloproteinase-1 by peroxynitrite","volume":"381","author":"Frears","year":"1996","journal-title":"FEBS Lett"},{"key":"10.1016\/j.phrs.2011.05.005_bib0910","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.febslet.2008.02.080","article-title":"Peroxynitrite inactivates human-tissue inhibitor of metalloproteinase-4","volume":"582","author":"Donnini","year":"2008","journal-title":"FEBS Lett"},{"key":"10.1016\/j.phrs.2011.05.005_bib0915","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1113\/expphysiol.2009.049874","article-title":"Role of matrix metalloproteinase-2 in the cardioprotective effect of ischaemic postconditioning","volume":"95","author":"Donato","year":"2010","journal-title":"Exp Physiol"},{"key":"10.1016\/j.phrs.2011.05.005_bib0920","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00395-008-0727-y","article-title":"Inhibiting matrix metalloproteinase-2 reduces protein release into coronary effluent from isolated rat hearts during ischemia-reperfusion","volume":"103","author":"Fert-Bober","year":"2008","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.phrs.2011.05.005_bib0925","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/sj.bjp.0707621","article-title":"Inhibition of matrix metalloproteinases prevents peroxynitrite-induced contractile dysfunction in the isolated cardiac myocyte","volume":"153","author":"Leon","year":"2008","journal-title":"Brit J Pharmacol"},{"key":"10.1016\/j.phrs.2011.05.005_bib0930","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0008-6363(01)00445-X","article-title":"Peroxynitrite-induced myocardial injury is mediated through matrix metalloproteinase-2","volume":"53","author":"Wang","year":"2002","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.phrs.2011.05.005_bib0935","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1161\/01.CIR.0000160936.91849.9F","article-title":"Near-infrared fluorescent imaging of matrix metalloproteinase activity after myocardial infarction","volume":"111","author":"Chen","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2011.05.005_bib0940","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11010-005-2540-3","article-title":"Reduction of myocardial infarct size by doxycycline: a role for plasmin inhibition","volume":"270","author":"Griffin","year":"2005","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.phrs.2011.05.005_bib0945","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/eurheartj\/ehi007","article-title":"Ischaemia-reperfusion injury activates matrix metalloproteinases in the human heart","volume":"26","author":"Lalu","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.phrs.2011.05.005_bib0950","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1161\/CIRCULATIONAHA.108.786640","article-title":"Dynamic changes in matrix metalloprotienase activity within the human myocardial interstitium during myocardial arrest and reperfusion","volume":"118","author":"Spinale","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2011.05.005_bib0955","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.jtcvs.2008.11.004","article-title":"A differential release of matrix metalloproteinases 9 and 2 during coronary artery bypass grafting and off-pump coronary artery bypass surgery","volume":"137","author":"Sokal","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.phrs.2011.05.005_bib0490","series-title":"In: clinicaltrialsgov","article-title":"Protection of the heart with doxycycline during coronary artery bypass grafting","author":"University of Alberta","year":"2000"},{"key":"10.1016\/j.phrs.2011.05.005_bib0960","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1161\/01.ATV.0000121571.78696.dc","article-title":"Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial","volume":"24","author":"Brown","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.phrs.2011.05.005_bib0965","doi-asserted-by":"crossref","first-page":"9S","DOI":"10.1016\/j.amjmed.2004.02.006","article-title":"Inflammation and atherosclerosis: role of C-reactive protein in risk assessment","volume":"116","author":"Libby","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.phrs.2011.05.005_bib0970","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1600-051X.2007.01104.x","article-title":"Effects of scaling and root planing and sub-antimicrobial dose doxycycline on oral and systemic biomarkers of disease in patients with both chronic periodontitis and coronary artery disease","volume":"34","author":"Tuter","year":"2007","journal-title":"J Clin Periodontol"},{"key":"10.1016\/j.phrs.2011.05.005_bib0975","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1161\/01.CIR.0000058700.41738.12","article-title":"Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease","volume":"107","author":"Blankenberg","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2011.05.005_bib0980","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jacc.2006.02.055","article-title":"Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial","volume":"48","author":"Hudson","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.phrs.2011.05.005_bib0985","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1365-2249.2009.03949.x","article-title":"Inhibition of matrix metalloproteinase-9 activity improves coronary outcome in an animal model of Kawasaki disease","volume":"157","author":"Lau","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.phrs.2011.05.005_bib0990","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1086\/587487","article-title":"Increased activities of cardiac matrix metalloproteinases matrix metalloproteinase (MMP)-2 and MMP-9 are associated with mortality during the acute phase of experimental Trypanosoma cruzi infection","volume":"197","author":"Gutierrez","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.phrs.2011.05.005_bib0995","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1023\/A:1025417529167","article-title":"Matrix metalloproteinase inhibitors attenuate endotoxemia induced cardiac dysfunction: a potential role for MMP-9","volume":"251","author":"Lalu","year":"2003","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.phrs.2011.05.005_bib1000","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1161\/01.ATV.0000065385.47152.FD","article-title":"Systemic arterial expression of matrix metalloproteinases 2 and 9 in acute Kawasaki disease","volume":"23","author":"Gavin","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.phrs.2011.05.005_bib1005","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1128\/CDLI.10.2.308-314.2003","article-title":"Elevated levels of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during the acute phase of Kawasaki disease","volume":"10","author":"Chua","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.phrs.2011.05.005_bib1010","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/S0140-6736(89)91910-7","article-title":"Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease","volume":"2","author":"Leung","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2011.05.005_bib1015","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1097\/01.CCM.0000127778.16609.EC","article-title":"Matrix metalloproteinase activities are altered in the heart and plasma during endotoxemia","volume":"32","author":"Lalu","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.phrs.2011.05.005_bib1020","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0140-6736(10)60061-X","article-title":"Chagas disease","volume":"375","author":"Rassi","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2011.05.005_bib1025","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S1471-4922(02)02283-3","article-title":"Chemokines, inflammation and Trypanosoma cruzi infection","volume":"18","author":"Teixeira","year":"2002","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.phrs.2011.05.005_bib1030","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.carpath.2005.11.008","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases in coxsackievirus-induced myocarditis","volume":"15","author":"Cheung","year":"2006","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.phrs.2011.05.005_bib1035","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1161\/CIRCULATIONAHA.107.733238","article-title":"Ablation of matrix metalloproteinase-9 increases severity of viral myocarditis in mice","volume":"117","author":"Cheung","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2011.05.005_bib1040","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.bcp.2007.07.004","article-title":"Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease","volume":"75","author":"Raffetto","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.phrs.2011.05.005_bib1045","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.cardiores.2005.08.002","article-title":"Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates","volume":"69","author":"Newby","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.phrs.2011.05.005_bib1050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.00048.2003","article-title":"Dual role of matrix metalloproteinases (MATRIXINS) in intimal thickening and atherosclerotic plaque rupture","volume":"85","author":"Newby","year":"2005","journal-title":"Physiol Rev"},{"key":"10.1016\/j.phrs.2011.05.005_bib1055","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1161\/01.ATV.0000151373.33830.41","article-title":"Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness","volume":"25","author":"Yasmin","year":"2005","journal-title":"Arterioscl Thromb Vas"},{"key":"10.1016\/j.phrs.2011.05.005_bib1060","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1161\/01.HYP.0000154680.44184.01","article-title":"Different involvement of extracellular matrix components in small and large arteries during chronic NO synthase inhibition","volume":"45","author":"Bouvet","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2011.05.005_bib1065","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1161\/HYPERTENSIONAHA.107.089631","article-title":"Role of matrix metalloproteinases in early hypertensive vascular remodeling","volume":"50","author":"Flamant","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2011.05.005_bib1070","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1161\/ATVBAHA.108.173898","article-title":"Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability","volume":"28","author":"Newby","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.phrs.2011.05.005_bib1075","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1172\/JCI0215334","article-title":"Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms","volume":"110","author":"Longo","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.phrs.2011.05.005_bib1080","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1161\/CIRCRESAHA.108.174367","article-title":"Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in Marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9","volume":"102","author":"Chung","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.phrs.2011.05.005_bib1085","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jtcvs.2009.10.039","article-title":"Effectiveness of combination of losartan potassium and doxycycline versus single-drug treatments in the secondary prevention of thoracic aortic aneurysm in Marfan syndrome","volume":"140","author":"Yang","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.phrs.2011.05.005_bib1090","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.yjmcc.2009.09.018","article-title":"Extracellular matrix alterations in hypertensive vascular remodeling","volume":"48","author":"Lemarie","year":"2009","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.phrs.2011.05.005_bib1095","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1128\/CMR.00047-08","article-title":"Matrix metalloproteinases as drug targets in infections caused by gram-negative bacteria and in septic shock","volume":"22","author":"Vanlaere","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.phrs.2011.05.005_bib1100","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1161\/01.RES.85.10.906","article-title":"Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor","volume":"85","author":"Fernandez-Patron","year":"1999","journal-title":"Circ Res"},{"key":"10.1016\/j.phrs.2011.05.005_bib1105","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/01.RES.87.8.670","article-title":"Vascular matrix metalloproteinase-2-dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction","volume":"87","author":"Fernandez-Patron","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.phrs.2011.05.005_bib1110","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1042\/BJ20040920","article-title":"Matrix metalloproteinase-2 cleavage of adrenomedullin produces a vasoconstrictor out of a vasodilator","volume":"383","author":"Martinez","year":"2004","journal-title":"Biochem J"},{"key":"10.1016\/j.phrs.2011.05.005_bib1115","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1161\/01.ATV.0000204344.90301.7c","article-title":"Vascular responses to alpha1-adrenergic receptors in small rat mesenteric arteries depend on mitochondrial reactive oxygen species","volume":"26","author":"Hao","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.phrs.2011.05.005_bib1120","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jvs.2004.08.035","article-title":"Matrix metalloproteinase-specific inhibition of Ca2+ entry mechanisms of vascular contraction","volume":"40","author":"Chew","year":"2004","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.phrs.2011.05.005_bib1125","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/hh0402.105899","article-title":"Alpha(4)beta(1) integrin activation of L-type calcium channels in vascular smooth muscle causes arteriole vasoconstriction","volume":"90","author":"Waitkus-Edwards","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.phrs.2011.05.005_bib1130","first-page":"H2065","article-title":"Integrin-mediated reduction in vascular smooth muscle [Ca2+]i induced by RGD-containing peptide","volume":"272","author":"D\u2019Angelo","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.phrs.2011.05.005_bib1135","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0031-6997(24)01493-5","article-title":"Proteinase-activated receptors","volume":"53","author":"Macfarlane","year":"2001","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.phrs.2011.05.005_bib1140","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nri1418","article-title":"Matrix metalloproteinases as modulators of inflammation and innate immunity","volume":"4","author":"Parks","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.phrs.2011.05.005_bib1145","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nrd2308","article-title":"Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases","volume":"6","author":"Hu","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.phrs.2011.05.005_bib1150","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1053\/jcan.2001.22317","article-title":"Myocardial dysfunction in septic shock: Part I","volume":"15","author":"Kumar","year":"2001","journal-title":"Clinical manifestation of cardiovascular dysfunction. J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.phrs.2011.05.005_bib1155","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","article-title":"Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care","volume":"29","author":"Angus","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.phrs.2011.05.005_bib1160","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0147-9563(96)80114-2","article-title":"The pathogenesis of septic shock","volume":"25","author":"Crowley","year":"1996","journal-title":"Heart Lung"},{"key":"10.1016\/j.phrs.2011.05.005_bib1165","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1540\/jsmr.43.117","article-title":"Vascular biology in sepsis: pathophysiological and therapeutic significance of vascular dysfunction","volume":"43","author":"Matsuda","year":"2007","journal-title":"J Smooth Muscle Res"},{"key":"10.1016\/j.phrs.2011.05.005_bib1170","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0006-291X(05)80068-3","article-title":"Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock","volume":"173","author":"Rees","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.phrs.2011.05.005_bib1175","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1476-5381.1992.tb09021.x","article-title":"Induction and potential biological relevance of a Ca2+ -independent nitric oxide synthase in the myocardium","volume":"105","author":"Schulz","year":"1992","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.phrs.2011.05.005_bib1180","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0022-3565(25)24291-4","article-title":"Lipopolysaccharide-induced hypotension and vascular hyporeactivity in the rat: tissue analysis of nitric oxide synthase mRNA and protein expression in the presence and absence of dexamethasone, NG-monomethyl-L-arginine or indomethacin","volume":"272","author":"Hom","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.phrs.2011.05.005_bib1185","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1476-5381.1995.tb14901.x","article-title":"The role of nitric oxide in cardiac depression induced by interleukin-1 beta and tumour necrosis factor-alpha","volume":"114","author":"Schulz","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.phrs.2011.05.005_bib1190","doi-asserted-by":"crossref","first-page":"H566","DOI":"10.1152\/ajpheart.2000.279.2.H566","article-title":"Src- and non-Src tyrosine kinases, and nitric oxide synthase induction in rat aorta in vitro","volume":"279","author":"Gui","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.phrs.2011.05.005_bib1195","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.cardiores.2004.01.014","article-title":"Measurements of nitric oxide concentration and hyporeactivity in rat superior mesenteric artery exposed to endotoxin","volume":"62","author":"Hernanz","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.phrs.2011.05.005_bib1200","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1161\/CIRCULATIONAHA.105.590232","article-title":"In vivo evidence for nitric oxide-mediated calcium-activated potassium-channel activation during human endotoxemia","volume":"114","author":"Pickkers","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2011.05.005_bib1205","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1124\/jpet.106.108100","article-title":"A role for nitric oxide-mediated peroxynitrite formation in a model of endotoxin-induced shock","volume":"319","author":"Cuzzocrea","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.phrs.2011.05.005_bib1210","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0014-5793(95)00322-Z","article-title":"Endotoxin triggers the expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in the rat aorta in vivo","volume":"363","author":"Szabo","year":"1995","journal-title":"FEBS Lett"},{"key":"10.1016\/j.phrs.2011.05.005_bib1215","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1600-0765.1990.tb00923.x","article-title":"Low-dose doxycycline therapy: effect on gingival and crevicular fluid collagenase activity in humans","volume":"25","author":"Golub","year":"1990","journal-title":"J Periodontal Res"},{"key":"10.1016\/j.phrs.2011.05.005_bib1220","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.bjp.0706823","article-title":"Matrix metalloproteinases contribute to endotoxin and interleukin-1beta induced vascular dysfunction","volume":"149","author":"Lalu","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.phrs.2011.05.005_bib1225","doi-asserted-by":"crossref","first-page":"H45","DOI":"10.1152\/ajpheart.00273.2009","article-title":"Inhibition of matrix metalloproteinase activity in vivo protects against vascular hyporeactivity in endotoxemia","volume":"298","author":"Cena","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.phrs.2011.05.005_bib1230","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1034\/j.1399-6576.2003.00059.x","article-title":"Differential release of matrix metalloproteinase-9 and nitric oxide following infusion of endotoxin to human volunteers","volume":"47","author":"Albert","year":"2003","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.phrs.2011.05.005_bib1235","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1080\/00365540600702058","article-title":"Matrix-metalloproteinases and their inhibitors are elevated in severe sepsis: prognostic value of TIMP-1 in severe sepsis","volume":"38","author":"Hoffmann","year":"2006","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.phrs.2011.05.005_bib1240","doi-asserted-by":"crossref","first-page":"R158","DOI":"10.1186\/cc8115","article-title":"Matrix metalloproteinase-9-10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis","volume":"13","author":"Lorente","year":"2009","journal-title":"Crit Care"},{"key":"10.1016\/j.phrs.2011.05.005_bib1245","first-page":"147","article-title":"Cytokine appearance in human endotoxemia and primate bacteremia","volume":"166","author":"Hesse","year":"1988","journal-title":"Surg Gynecol Obstet"},{"key":"10.1016\/j.phrs.2011.05.005_bib1250","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1172\/JCI113431","article-title":"Interleukin 1 induces a shock-like state in rabbits, Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition","volume":"81","author":"Okusawa","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1016\/j.phrs.2011.05.005_bib1255","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejphar.2007.12.019","article-title":"Endothelial dependence of matrix metalloproteinase-mediated vascular hyporeactivity caused by lipopolysaccharide","volume":"582","author":"Cena","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.phrs.2011.05.005_bib1260","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.bcp.2005.04.047","article-title":"Targeting neutrophil collagenase\/matrix metalloproteinase-8 and gelatinase B\/matrix metalloproteinase-9 with a peptidomimetic inhibitor protects against endotoxin shock","volume":"70","author":"Hu","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.phrs.2011.05.005_bib1265","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/1521-4141(200208)32:8<2163::AID-IMMU2163>3.0.CO;2-Q","article-title":"B deficiency protects against endotoxin shock","volume":"32","author":"Dubois","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.phrs.2011.05.005_bib1270","first-page":"S99","article-title":"Matrix metalloproteinse-2 may cleave calponin in vascular smooth muscle during endotoxemia","volume":"87","author":"Castro","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.phrs.2011.05.005_bib1275","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/01.shk.0000245019.63246.31","article-title":"Chemically modified tetracycline (COL-3) improves survival if given 12 but not 24 hours after cecal ligation and puncture","volume":"26","author":"Halter","year":"2006","journal-title":"Shock"},{"key":"10.1016\/j.phrs.2011.05.005_bib1280","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1097\/01.CCM.0000169880.82060.F7","article-title":"Effect of chemically modified tetracycline on transforming growth factor-beta1 and caspase-3 activation in liver of septic rats","volume":"33","author":"Maitra","year":"2005","journal-title":"Crit Care Med"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661811001411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661811001411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:07:03Z","timestamp":1741219623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661811001411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":165,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S1043661811001411"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2011.05.005","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}